Literature DB >> 3967832

Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.

V Binder, C Hendriksen, S Kreiner.   

Abstract

All patients in the county of Copenhagen (approximately 500 000 inhabitants) with Crohn's disease, n = 185 were followed regularly between 1960 and 1978. The survival, the course of disease, the frequency of surgery, and the working capacity were estimated for the first 10 years of disease on the basis of the follow up results. The observation time ranged from 1-18 years with a median of 5.5 years for clinical observations, 5.8 years for survival, and 9.5 years for the occurrence of gastrointestinal cancer. The follow up was 100% concerning survival and cancer. The survival did not differ from that of the age- and sex-matched background population. Cancer was seen in only one of 185 patients corresponding to an annual risk of 0.06% and a cumulated risk after 10 years of 0.56, 95% confidence limits: 0.1-3.1%. The cancer was localised in the ileum. For all years, about 45% of the patients were without clinical symptoms of their disease, in 30% the clinical disease activity was low, and in 25% moderate to high. Among the patients with active disease, the course within the individual year was continuous in about one third and intermittent in about two thirds. After 10 years, 99% of the patients had experienced at least one relapse. The operation rate was 33% in the year of diagnosis, 13% in the following year, and then about 3% per year independent of whether or not the patient had been treated surgically in the past. After 10 years, 45% of the patients had not been treated surgically, 42% had had only one operation, and 13% had had two or more operations for their Crohn's disease. The working capacity was normal in about 75% of the patients for all years except the year of diagnosis. About 15-20% of the patients who had had the disease for more than five years were disabled as compared with about 4.4% of the background population. These results indicate that some of the patients with Crohn's disease run a more serious course with continuing symptoms despite of medical treatment and frequent surgical interventions. Most patients, however, remained capable for work and were able to lead a normal life.

Entities:  

Mesh:

Year:  1985        PMID: 3967832      PMCID: PMC1432429          DOI: 10.1136/gut.26.2.146

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Survival rate in Crohn's disease and ulcerative colitis.

Authors:  L Storgaard; N Bischoff; F W Henriksen; K Fischerman; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

2.  Recurrence and reoperation for Crohn's disease: the role of disease location in prognosis.

Authors:  M R Lock; R G Farmer; V W Fazio; D G Jagelman; I C Lavery; F L Weakley
Journal:  N Engl J Med       Date:  1981-06-25       Impact factor: 91.245

3.  Crohn's disease of the distal ileum.

Authors:  C S Higgens; R N Allan
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

4.  Course and prognosis of Crohn's disease.

Authors:  S C Truelove; A S Pena
Journal:  Gut       Date:  1976-03       Impact factor: 23.059

5.  Mortality in Crohn's disease.

Authors:  P Prior; S Gyde; W T Cooke; J A Waterhouse; R N Allan
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

6.  Recurrence of Crohn's disease after primary excisional surgery.

Authors:  F T De Dombal; I Burton; J C Goligher
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

7.  Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978.

Authors:  V Binder; H Both; P K Hansen; C Hendriksen; S Kreiner; K Torp-Pedersen
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

8.  The social toll of Crohn's disease.

Authors:  B G Gazzard; H L Price; G W Libby; A M Dawson
Journal:  Br Med J       Date:  1978-10-21

9.  Malignancy in Crohn's disease.

Authors:  S N Gyde; P Prior; J C Macartney; H Thompson; J A Waterhouse; R N Allan
Journal:  Gut       Date:  1980-12       Impact factor: 23.059

10.  Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.

Authors:  C Hendriksen; S Kreiner; V Binder
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

View more
  57 in total

1.  Colon capsule endoscopy: Advantages, limitations and expectations. Which novelties?

Authors:  Maria Elena Riccioni; Riccardo Urgesi; Rossella Cianci; Alessandra Bizzotto; Cristiano Spada; Guido Costamagna
Journal:  World J Gastrointest Endosc       Date:  2012-04-16

Review 2.  Recent epidemiology of ulcerative colitis and Crohn's disease.

Authors:  J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

3.  Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.

Authors:  Bharati Kochar; Millie D Long; Edward Shelton; Lorraine Young; Francis A Farraye; Vijay Yajnik; Hans Herfarth
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

Review 4.  Economic implications of biological therapies for Crohn's disease: review of infliximab.

Authors:  Keith Bodger
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital.

Authors:  I T Weterman; I Biemond; A S Peña
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

6.  Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients.

Authors:  Stefano Scaringi; Carmela Di Martino; Daniela Zambonin; Marilena Fazi; Giuseppe Canonico; Francesca Leo; Ferdinando Ficari; Francesco Tonelli
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

Review 7.  Surgery and diagnostic imaging in abdominal Crohn's disease.

Authors:  Fiorenzo Botti; Flavio Caprioli; Diego Pettinari; Alberto Carrara; Andrea Magarotto; Ettore Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-16

Review 8.  Postoperative Crohn's disease recurrence: a practical approach.

Authors:  Pilar Nos; Eugeni Domenech
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

9.  Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.

Authors:  D G Forcione; M J Rosen; J B Kisiel; B E Sands
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 10.  Methotrexate for induction of remission in refractory Crohn's disease.

Authors:  John W D McDonald; Yongjun Wang; David J Tsoulis; John K MacDonald; Brian G Feagan
Journal:  Cochrane Database Syst Rev       Date:  2014-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.